# EDGAR Filing Document

**Accession Number:** 0001436425
**File Stem:** 0001127602-23-010263
**Filing Date:** 2023-3
**Character Count:** 9007
**Document Hash:** d26e05233d07b411bd7d54894943cd4c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001127602-23-010263.hdr.sgml**: 20230315

**ACCESSION NUMBER**: 0001127602-23-010263

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230313

**FILED AS OF DATE**: 20230315

**DATE AS OF CHANGE**: 20230315

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** FREYOU JASON
- **CENTRAL INDEX KEY:** 0001441550

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-34190
- **FILM NUMBER:** 23734383

**MAIL ADDRESS:**
- **STREET 1:** 503 KALISTE SALOOM ROAD
- **CITY:** LAFAYETTE
- **STATE:** LA
- **ZIP:** 70508
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HOME BANCORP, INC.
- **CENTRAL INDEX KEY:** 0001436425
- **STANDARD INDUSTRIAL CLASSIFICATION:** SAVINGS INSTITUTIONS, NOT FEDERALLY CHARTERED [6036]
- **IRS NUMBER:** 711051785
- **STATE OF INCORPORATION:** LA
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 503 KALISTE SALOOM ROAD
- **CITY:** LAFAYETTE
- **STATE:** LA
- **ZIP:** 70508
- **BUSINESS PHONE:** (337) 237-1960

**MAIL ADDRESS:**
- **STREET 1:** 503 KALISTE SALOOM ROAD
- **CITY:** LAFAYETTE
- **STATE:** LA
- **ZIP:** 70508

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>FREYOU JASON<br><sub>(Last) (First) (Middle)</sub><br>C/O HOME BANCORP, INC.<br>503 KALISTE SALOOM ROAD<br><sub>(Street)</sub><br>LAFAYETTE, LA 70598<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-13 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_SEVP & Chief Operations Office_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>HOME BANCORP, INC. [ HBCP ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2023-03-13 | 2023-03-13 | F |  | 64 | D | $35.67 | 9268.18 | D<sup>(1)(2)(3)(4)(5)(6)(7)</sup> |  |
| Common Stock |  |  |  |  |  |  |  | 7906.0292 | I | 401(k) |
| Common Stock |  |  |  |  |  |  |  | 2584.1798 | I | By ESOP |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Employee Stock Option (Right to Buy) | $21.16 |  |  |  |  |  |  | <sup>(8)</sup> | 2025-03-12 | Common Stock | 800 |  | 800 | D |  |
| Employee Stock Option (Right to Buy) | $28.00 |  |  |  |  |  |  | <sup>(9)</sup> | 2026-05-23 | Common Stock | 2100 |  | 2100 | D |  |
| Employee Stock Option (Right to Buy) | $35.26 |  |  |  |  |  |  | <sup>(10)</sup> | 2027-05-12 | Common Stock | 1325 |  | 1325 | D |  |
| Employee Stock Option (Right to Buy) | $45.12 |  |  |  |  |  |  | <sup>(11)</sup> | 2028-05-12 | Common Stock | 800 |  | 800 | D |  |
| Employee Stock Option (Right to Buy) | $35.85 |  |  |  |  |  |  | <sup>(12)</sup> | 2029-05-23 | Common Stock | 1000 |  | 1000 | D |  |
| Employee Stock Option (Right to Buy) | $21.99 |  |  |  |  |  |  | <sup>(13)</sup> | 2030-03-12 | Common Stock | 1000 |  | 1000 | D |  |
| Employee Stock Option (Right to Buy) | $36.77 |  |  |  |  |  |  | <sup>(14)</sup> | 2031-05-12 | Common Stock | 1500 |  | 1500 | D |  |

---

### Footnotes:

(1) Includes 800 shares awarded on March 12, 2015 pursuant to the Issuer's 2009 Recognition and Retention Plan that vest in equal installments at the rate of 20% per year commencing on March 12, 2016.

(2) Includes the grant of 1,200 restricted stock units pursuant to the Issuer's 2014 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2017 and that may be settled only in shares of the Issuer's common stock.

(3) Includes the grant of 1,250 restricted stock units pursuant to the Issuer's 2014 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2022 and that may be settled only in shares of the Issuer's common stock.

(4) Includes the grant of 700 restricted stock units pursuant to the Issuer's 2014 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2018 and that may be settled only in shares of the Issuer's common stock.

(5) Includes the grant of 825 restricted stock units pursuant to the Issuer's 2014 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2019 and that may be settled only in shares of the Issuer's common stock.

(6) Includes the grant of 925 restricted stock units pursuant to the Issuer's 2014 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2020 and that may be settled only in shares of the Issuer's common stock.

(7) Includes the grant of 940 restricted stock units pursuant to the Issuer's 2014 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on March 12, 2021 and that may be settled only in shares of the Issuer's common stock.

(8) Options granted under the Issuer's 2009 Stock Option Plan and become exercisable in five equal installments beginning on March 12, 2016.

(9) The options vest and become exercisable in five equal installments beginning May 23, 2017.

(10) The options vest and become exercisable in five equal installments beginning May 12, 2018.

(11) The options vest and become exercisable in five equal installments beginning May 12, 2019.

(12) The options vest and become exercisable in five equal annual installments beginning May 23, 2020.

(13) The options vest and become exercisable in five equal annual installments beginning March 12, 2021.

(14) The options vest and become exercisable in five equal installments beginning May 12, 2022.

**Signature:** /s/ Jason P. Freyou  
**Date:** 2023-03-15

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**